Angelica Loskog

Company: Lokon Pharma AB

Job title: Chief Executive Officer

Seminars:

Triplet Therapy to Combat Pancreatic Cancer 10:30 am

Pancreatic cancer has high stroma and myeloid cell content and has a dismal prognosis LOAd703 is an adenovirus-based therapy encoding transgenes that target CD40 and 41BB in the tumor microenvironment (tumor and stroma) to generate anti-tumor immunity as well as replicating in cancer cells to cause oncolysis with release of antigens LOAd703 is currently evaluated…Read more

day: Day Two